Defining the Optimal Treatment of Locally Advanced Esophageal Cancer: A Systematic Review and Decision Analysis Andrew J. Graham, MD, MS, Fiona M. Shrive, PhD, William A. Ghali, MD, MPH, Braden J. Manns, MD, MS, Sean C. Grondin, MD, MPH, Richard J. Finley, MD, Joanne Clifton, MS The Annals of Thoracic Surgery Volume 83, Issue 4, Pages 1257-1264 (April 2007) DOI: 10.1016/j.athoracsur.2006.11.061 Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Modeled survival curves resulting from the Markov cohort analysis. (A) Survival. (B) Quality-adjusted life-years gained. (Light solid line = surgery; dotted line = chemoradiation therapy plus surgery; heavy dashed line = chemotherapy plus surgery; heavy solid line = surgery plus chemoradiation therapy.) The Annals of Thoracic Surgery 2007 83, 1257-1264DOI: (10.1016/j.athoracsur.2006.11.061) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions